Revealing the role: Human papillomavirus as a catalyst in head and neck cancer

• HPV's Role in HNC: The manuscript explores HPV's significant contribution to head and neck cancers (HNC), particularly oropharyngeal cancers, highlighting its distinct clinical and molecular characteristics compared to HPV-negative HNCs. • Diagnostic and Prognostic Implications: It discusses the importance of assessing HPV status in HNC diagnosis and prognosis, showcasing how HPV-positive tumors often exhibit better treatment response rates and improved overall survival compared to HPV-negative tumors. • Tailored Treatment Strategies: The manuscript emphasizes the need for personalized treatment approaches for HPV-related HNCs, including the exploration of novel therapies such as immunotherapy, to optimize treatment outcomes while minimizing adverse effects. • Public Health Initiatives: It underscores the significance of public health initiatives aimed at HPV prevention and vaccination, emphasizing their critical role in reducing the global burden of HPV-related HNCs through increased vaccination rates and awareness campaigns.